Skip to main content
. 2023 Jan 17;45(1):2120821. doi: 10.1080/0886022X.2022.2120821

Table 2.

Effects of combination therapy with DHA and BMSCs on mouse podocyte proliferation in vitro.

Groups Survival rate (%)
Control 100.00 ± 0.00
MN 72.36 ± 8.42*
MN + SB431542 80.54 ± 9.53*#
MN + DHA + BMSCs 90.062 ± 7.27*#
MN + DHA + BMSCs + SB431542 85.16 ± 5.16*#@$

*p < .05 versus control group; #p < .05 versus MN model group; @p < .05 versus MN + SB431542 group; $p < .05 versus MN + DHA + BMSCs group.